Interphex Focuses on Counterfeit Prevention - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Interphex Focuses on Counterfeit Prevention
Interphex provided an opportunity to examine the latest pharmaceutical packaging concepts and packaging machines.


Pharmaceutical Technology



High-frequency phase-jitter modulation technology developed by Magellan Technology makes it possible for each RFID-tagged item in this tote to be read at line speeds using tags from UPM Raflatac and a tunnel reader from Balogh U.S.A.
Forensically invisible markers or taggants that are detectable only by proprietary reading devices can provide multiple levels of security, including basic pass–fail authentication, unique particle-signature identification for item-level recognition and tracking, and additional proprietary levels of security. Built-in safeguards prevent reverse engineering. Taggants can be mixed into almost any packaging material including paper pulp, ink, varnish, laser toner, molten metals, and resin or applied as a coating. Taggants can be detected at levels as low as two parts per million and can add as little as $0.002 to the cost of a package ("Kodak Traceless System," Kodak Security, Brand Authentication & ID Systems, Burnaby, BC, Canada, http://www.kodak.com/go/traceless; taggant technology, InkSure Technologies, Fort Lauderdale, FL, http://www.inksure.com/; and "Visi-Tag" brand protection, Rexam Closures & Containers, Evansville, IN, http://www.rexam.com/closures).

Synthesized DNA code fragments can serve as biomolecular markers. Unique markers are created for each customer and are divided into two parts. When the parts are combined, a hybridization reaction assembles the finished, detectable DNA code segment. Field confirmation is performed with a handheld reader that measures a luminescent signal from the DNA ("Bio-Molecular Marker," DuPont).


Multisorb's Moisture Management Analysis services help determine the type and quantity of sorbent needed to manage moisture for specific product–package combinations.
Another layered approach combines overt, covert, and semicovert technologies such as holographic labeling with a destructive adhesive, 14-point security board with fluorescent fibers, infrared inks in predetermined places on the package, dual-wavelength UV spot varnish, nano-bar code technology or X-ray fluorescing frequency particles in a coating, microtaggants in the glue, radio frequency identification (RFID) tags, and proprietary markers ("Dosepak BP," Centuria Brand & Supply Chain Security, MeadWestvaco Healthcare Packaging, Stamford, CT, http://www.mwvhealthcare.com/).

Screened keys laid on top of printed label graphics reveal otherwise invisible watermarks. Multiple images such as a company name, logo, and numeric codes can be hidden in the same area to provide a different authentication device for various levels of the supply chain ("AuthentiKey," Tursso Companies, Inc., St. Paul, MN, http://www.tursso.com/).


A print-registered, tear-initiation point on child-resistant pouches from Amcor Flexibles can be positioned anywhere on the pouch.




ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here